Mabpharm Limited announced that Dr. Qian Weizhu has resigned from the position of executive director, chief executive officer and member of the nomination committee of the company due to work arrangements, with effect from October 28, 2020. Upon resignation, Dr. Qian will be redesignated as a consultant of the company with effect immediately. The Board further announces that Dr. Wang Hao ("Dr. Wang") has been appointed as the chief executive officer of the company; and (ii) Mr. Tao Jing ("Mr. Tao") has been appointed as an executive director and a member of the Nomination Committee of the company, with effect from October 28, 2020.